New York State Teachers Retirement System Sells 800 Shares of Core Laboratories Inc. (NYSE:CLB)

New York State Teachers Retirement System reduced its stake in shares of Core Laboratories Inc. (NYSE:CLB) by 3.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 19,818 shares of the oil and gas company’s stock after selling 800 shares during the period. New York State Teachers Retirement System’s holdings in Core Laboratories were worth $350,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC bought a new stake in Core Laboratories in the third quarter worth $31,000. State of Wyoming lifted its stake in Core Laboratories by 43.1% in the second quarter. State of Wyoming now owns 1,447 shares of the oil and gas company’s stock worth $34,000 after purchasing an additional 436 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in Core Laboratories by 9,913.3% in the second quarter. Tower Research Capital LLC TRC now owns 1,502 shares of the oil and gas company’s stock worth $35,000 after purchasing an additional 1,487 shares during the last quarter. UBS Group AG lifted its stake in Core Laboratories by 171.6% in the third quarter. UBS Group AG now owns 3,200 shares of the oil and gas company’s stock worth $43,000 after purchasing an additional 2,022 shares during the last quarter. Finally, PNC Financial Services Group Inc. lifted its stake in Core Laboratories by 184.9% in the fourth quarter. PNC Financial Services Group Inc. now owns 2,934 shares of the oil and gas company’s stock worth $59,000 after purchasing an additional 1,904 shares during the last quarter. 97.81% of the stock is owned by institutional investors.

Core Laboratories Price Performance

CLB stock opened at $16.99 on Friday. Core Laboratories Inc. has a 12-month low of $13.82 and a 12-month high of $27.94. The company has a current ratio of 2.53, a quick ratio of 1.72 and a debt-to-equity ratio of 0.71. The firm’s 50-day moving average price is $16.05 and its two-hundred day moving average price is $17.86. The stock has a market capitalization of $796.15 million, a price-to-earnings ratio of 19.76, a PEG ratio of 0.96 and a beta of 2.40.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings results on Wednesday, January 31st. The oil and gas company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.01). Core Laboratories had a net margin of 8.03% and a return on equity of 15.19%. The company had revenue of $128.21 million for the quarter, compared to analysts’ expectations of $127.80 million. During the same quarter in the prior year, the firm earned $0.23 EPS. As a group, equities analysts predict that Core Laboratories Inc. will post 0.81 earnings per share for the current year.

Core Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 4th. Investors of record on Monday, February 12th were given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.24%. The ex-dividend date was Friday, February 9th. Core Laboratories’s dividend payout ratio is currently 4.65%.

Analyst Upgrades and Downgrades

CLB has been the subject of several recent research reports. Bank of America lowered their price target on shares of Core Laboratories from $17.00 to $16.00 and set an “underperform” rating for the company in a research note on Monday. StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, January 20th. Finally, Stifel Nicolaus decreased their price objective on shares of Core Laboratories from $21.00 to $17.00 and set a “hold” rating on the stock in a research report on Monday, February 5th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $18.50.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.